138 Use of rpoB sequence clustering for species-level identification of the Elizabethkingia genus from UK CF patients, and an investigation of associated antimicrobial … D Kenna, A Fuller, K Martin, R Pike, C Perry, J Shah, D Lilley, R Hill, ... Journal of Cystic Fibrosis 1 (16), S101, 2017 | | 2017 |
160 Molecular profiling demonstrates clustering of Mycobacterium abscessus isolates in CF patients from a single centre H Green, R Bright-Thomas, P Barry, A Horsley, B Isalska, N Woodford, ... Journal of Cystic Fibrosis, S87, 2014 | | 2014 |
A curated dataset of complete Enterobacteriaceae plasmids compiled from the NCBI nucleotide database A Orlek, H Phan, AE Sheppard, M Doumith, M Ellington, T Peto, D Crook, ... Data in brief 12, 423-426, 2017 | 41 | 2017 |
A large, refractory nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Escherichia coli demonstrates carbapenemase gene outbreaks involving sink sites require … V Decraene, HTT Phan, R George, DH Wyllie, O Akinremi, Z Aiken, ... Antimicrobial agents and chemotherapy 62 (12), 10.1128/aac. 01689-18, 2018 | 131* | 2018 |
A multispecies cluster of GES-5 carbapenemase–producing Enterobacterales linked by a geographically disseminated plasmid MJ Ellington, F Davies, E Jauneikaite, KL Hopkins, JF Turton, G Adams, ... Clinical Infectious Diseases 71 (10), 2553-2560, 2020 | 28 | 2020 |
A Practical Guide to Clinical Bacteriology N WOODFORD | | |
A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK E Taylor, AM Bal, I Balakrishnan, NM Brown, P Burns, M Clark, M Diggle, ... Journal of Antimicrobial Chemotherapy 76 (9), 2428-2436, 2021 | 11 | 2021 |
A rapid molecular assay for the detection of antibiotic resistance determinants in causal agents of infective endocarditis JE Moore, BC Millar, X Yongmin, N Woodford, S Vincent, CE Goldsmith, ... Journal of applied microbiology 90 (5), 719-726, 2001 | 31 | 2001 |
A risk assessment of antibiotic pan-drug-resistance in the UK: Bayesian analysis of an expert elicitation study D Carter, A Charlett, S Conti, JV Robotham, AP Johnson, DM Livermore, ... Antibiotics 6 (1), 9, 2017 | 23 | 2017 |
A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with … CG Giske, L Gezelius, Ø Samuelsen, M Warner, A Sundsfjord, ... Clinical microbiology and infection 17 (4), 552-556, 2011 | 324 | 2011 |
A ten-year review of Carbapenemase Producing Enterobacterales (CPE) in London, United Kingdom B Patel, K Hopkins, D Meunier, P Staves, S Hopkins, N Woodford Infection Control & Hospital Epidemiology 41 (S1), s6-s7, 2020 | 1 | 2020 |
A two-centre evaluation of RAPIDEC® CARBA NP for carbapenemase detection in Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter spp. MH Kabir, D Meunier, KL Hopkins, CG Giske, N Woodford Journal of Antimicrobial Chemotherapy 71 (5), 1213-1216, 2016 | 55 | 2016 |
Activities of NXL104 Combinations with Ceftazidime and Aztreonam against Carbapenemase-Producing Enterobacteriaceae DM Livermore, S Mushtaq, M Warner, J Zhang, S Maharjan, M Doumith, ... Antimicrobial agents and chemotherapy 55 (1), 390-394, 2011 | 303 | 2011 |
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates DM Livermore, S Mushtaq, M Warner, JC Zhang, S Maharjan, M Doumith, ... Journal of Antimicrobial Chemotherapy 66 (1), 48-53, 2011 | 315 | 2011 |
Activity of aztreonam/avibactam against metallo-β-lactamase-producing Enterobacterales from the UK: impact of penicillin-binding protein-3 inserts and CMY-42 β-lactamase in … DM Livermore, S Mushtaq, A Vickers, N Woodford International Journal of Antimicrobial Agents 61 (5), 106776, 2023 | 15 | 2023 |
Activity of aztreonam/avibactam and ceftazidime/avibactam against Enterobacterales with carbapenemase-independent carbapenem resistance S Mushtaq, A Vickers, N Woodford, DM Livermore International Journal of Antimicrobial Agents 63 (3), 107081, 2024 | 3 | 2024 |
Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters S Mushtaq, N Woodford, R Hope, R Adkin, DM Livermore Journal of Antimicrobial Chemotherapy 68 (7), 1601-1608, 2013 | 45 | 2013 |
Activity of cefepime/zidebactam (WCK 5222) against ‘problem’antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory S Mushtaq, P Garello, A Vickers, N Woodford, DM Livermore Journal of Antimicrobial Chemotherapy 76 (6), 1511-1522, 2021 | 22 | 2021 |
Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015–16 DM Livermore, D Meunier, KL Hopkins, M Doumith, R Hill, R Pike, ... Journal of Antimicrobial Chemotherapy 73 (3), 648-657, 2018 | 80 | 2018 |
Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles DM Livermore, S Mushtaq, D Meunier, KL Hopkins, R Hill, R Adkin, ... Journal of Antimicrobial Chemotherapy 72 (8), 2278-2289, 2017 | 125 | 2017 |